These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 20845411)

  • 1. Asymmetric dimethylarginine (ADMA) induces chronic kidney disease through a mechanism involving collagen and TGF-β1 synthesis.
    Mihout F; Shweke N; Bigé N; Jouanneau C; Dussaule JC; Ronco P; Chatziantoniou C; Boffa JJ
    J Pathol; 2011 Jan; 223(1):37-45. PubMed ID: 20845411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress.
    Suda O; Tsutsui M; Morishita T; Tasaki H; Ueno S; Nakata S; Tsujimoto T; Toyohira Y; Hayashida Y; Sasaguri Y; Ueta Y; Nakashima Y; Yanagihara N
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1682-8. PubMed ID: 15217805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renoprotective effects of melatonin in young spontaneously hypertensive rats with L-NAME.
    Cheng MC; Wu TH; Huang LT; Tain YL
    Pediatr Neonatol; 2014 Jun; 55(3):189-95. PubMed ID: 24268813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dimethylarginine dimethylaminohydrolase prevents progression of renal dysfunction by inhibiting loss of peritubular capillaries and tubulointerstitial fibrosis in a rat model of chronic kidney disease.
    Matsumoto Y; Ueda S; Yamagishi S; Matsuguma K; Shibata R; Fukami K; Matsuoka H; Imaizumi T; Okuda S
    J Am Soc Nephrol; 2007 May; 18(5):1525-33. PubMed ID: 17409314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism of long-term low-dose asymmetric dimethylarginine inducing transforming growth factor-β expression in endothelial cells.
    Feng Y; Zhang D; Zhang Y; Zhang Q; Liu W
    Int J Mol Med; 2013 Jan; 31(1):67-74. PubMed ID: 23175152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nitric oxide on renal interstitial fibrosis in rats with unilateral ureteral obstruction.
    Sun D; Wang Y; Liu C; Zhou X; Li X; Xiao A
    Life Sci; 2012 Jun; 90(23-24):900-9. PubMed ID: 22572614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fasudil, a Rho-kinase inhibitor, reverses L-NAME exacerbated severe nephrosclerosis in spontaneously hypertensive rats.
    Koshikawa S; Nishikimi T; Inaba C; Akimoto K; Matsuoka H
    J Hypertens; 2008 Sep; 26(9):1837-48. PubMed ID: 18698220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelin-1 gene expression and synthesis and effect on renal type I collagen synthesis and nephroangiosclerosis during nitric oxide synthase inhibition in rats.
    Tharaux PL; Chatziantoniou C; Casellas D; Fouassier L; Ardaillou R; Dussaule JC
    Circulation; 1999 Apr; 99(16):2185-91. PubMed ID: 10217661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans.
    Kielstein JT; Impraim B; Simmel S; Bode-Böger SM; Tsikas D; Frölich JC; Hoeper MM; Haller H; Fliser D
    Circulation; 2004 Jan; 109(2):172-7. PubMed ID: 14662708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of nitric oxide modulation on TGF-beta1 and matrix proteins in chronic cyclosporine nephrotoxicity.
    Shihab FS; Yi H; Bennett WM; Andoh TF
    Kidney Int; 2000 Sep; 58(3):1174-85. PubMed ID: 10972680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide inhibition induces early activation of type I collagen gene in renal resistance vessels and glomeruli in transgenic mice. Role of endothelin.
    Chatziantoniou C; Boffa JJ; Ardaillou R; Dussaule JC
    J Clin Invest; 1998 Jun; 101(12):2780-9. PubMed ID: 9637712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of renal vascular and glomerular fibrosis by epidermal growth factor receptor inhibition.
    François H; Placier S; Flamant M; Tharaux PL; Chansel D; Dussaule JC; Chatziantoniou C
    FASEB J; 2004 May; 18(7):926-8. PubMed ID: 15033924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition.
    Kaikita K; Fogo AB; Ma L; Schoenhard JA; Brown NJ; Vaughan DE
    Circulation; 2001 Aug; 104(7):839-44. PubMed ID: 11502712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADMA, homocysteine and redox status improvement affected by 7-nitroindazole in spontaneously hypertensive rats.
    Dovinová I; Hrabárová E; Jansen E; Kvandová M; Majzúnová M; Berenyiová A; Barančík M
    Biomed Pharmacother; 2018 Oct; 106():1478-1483. PubMed ID: 30119222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential roles of plasminogen activator system in coronary vascular remodeling induced by long-term nitric oxide synthase inhibition.
    Kaikita K; Schoenhard JA; Painter CA; Ripley RT; Brown NJ; Fogo AB; Vaughan DE
    J Mol Cell Cardiol; 2002 Jun; 34(6):617-27. PubMed ID: 12054849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the endogenous nitric oxide inhibitor asymmetric dimethylarginine (ADMA) and brain-derived neurotrophic factor (BDNF) in depression and behavioural changes: clinical and preclinical data in chronic kidney disease.
    Kielstein H; Suntharalingam M; Perthel R; Song R; Schneider SM; Martens-Lobenhoffer J; Jäger K; Bode-Böger SM; Kielstein JT
    Nephrol Dial Transplant; 2015 Oct; 30(10):1699-705. PubMed ID: 26175142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?
    Rochette L; Lorin J; Zeller M; Guilland JC; Lorgis L; Cottin Y; Vergely C
    Pharmacol Ther; 2013 Dec; 140(3):239-57. PubMed ID: 23859953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of inducible nitric oxide synthase and dimethyl arginine dimethylaminohydrolase in Nω-nitro-L-arginine methyl ester (L-NAME)-induced hypertension.
    Leo MD; Kandasamy K; Subramani J; Tandan SK; Kumar D
    Cardiovasc Pathol; 2015; 24(1):49-55. PubMed ID: 25294342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of nitric oxide deficiency in the development of hypertension in hydronephrotic animals.
    Carlström M; Brown RD; Edlund J; Sällström J; Larsson E; Teerlink T; Palm F; Wåhlin N; Persson AE
    Am J Physiol Renal Physiol; 2008 Feb; 294(2):F362-70. PubMed ID: 18032548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic renal impairment and DDAH2-1151 A/C polymorphism determine ADMA levels in type 2 diabetic subjects.
    Marra M; Marchegiani F; Ceriello A; Sirolla C; Boemi M; Franceschi C; Spazzafumo L; Testa I; Bonfigli AR; Cucchi M; Testa R
    Nephrol Dial Transplant; 2013 Apr; 28(4):964-71. PubMed ID: 23129820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.